Cargando…
Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a very lethal disease that can develop therapy resistance over time. The dense stroma in PDAC plays a critical role in tumor progression and resistance. How this stroma interacts with the tumor cells and how this is influenced by chemotherapy re...
Autores principales: | Bulle, Ashenafi, Dekervel, Jeroen, Deschuttere, Lise, Nittner, David, Libbrecht, Louis, Janky, Rekin's, Plaisance, Stéphane, Topal, Baki, Coosemans, An, Lambrechts, Diether, Van Cutsem, Eric, Verslype, Chris, van Pelt, Jos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058407/ https://www.ncbi.nlm.nih.gov/pubmed/32145636 http://dx.doi.org/10.1016/j.tranon.2020.01.004 |
Ejemplares similares
-
Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts
por: Bulle, Ashenafi, et al.
Publicado: (2020) -
Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response
por: Dekervel, Jeroen, et al.
Publicado: (2016) -
A Global Risk Score (GRS) to Simultaneously Predict Early and Late Tumor Recurrence Risk after Resection of Hepatocellular Carcinoma()
por: Dekervel, Jeroen, et al.
Publicado: (2016) -
DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer
por: Galle, Eva, et al.
Publicado: (2020) -
PD-1(-) CD45RA(+) effector-memory CD8 T cells and CXCL10(+) macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma
por: Cappuyns, Sarah, et al.
Publicado: (2023)